{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:28Z","timestamp":1793978848490,"version":"4.8.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cancer Research UK Cambridge Institute, University of Cambridge","id":[{"id":"https:\/\/ror.org\/013meh722","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Newcastle University"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Smoking tobacco cigarettes affects the metabolism of several antipsychotic medications by inducing CYP1A2 enzymes. Clozapine is particularly sensitive to this effect, as CYP1A2 induction increases the plasma clearance of the drug, resulting in lower clozapine plasma concentrations and a reduced clozapine concentration\u2013dose (C\/D) ratio than that in nonsmokers. Although the increase in clozapine concentrations and C\/D ratios after smoking cessation is well-established, the effects of switching to e-cigarettes (electronic cigarettes or vapes) or initiating vaping without prior smoking is not well-understood. This review aimed to address these gaps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The literature was searched for articles on patients taking clozapine who used or had used e-cigarettes, including those who switched from tobacco cigarettes. Eligible publications were reviewed and information on patient demographics, psychiatric history, smoking status, clozapine dose, plasma clozapine concentrations, and C\/D ratios before and after vaping were extracted. When not reported in the articles, the C\/D ratio was calculated using the available plasma clozapine concentrations and corresponding clozapine dose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Five articles were identified, all case reports describing 5 patients (4 male) who switched from tobacco cigarettes to e-cigarettes while taking clozapine. Switching resulted in increased C\/D ratios and plasma clozapine concentrations, although the magnitude of this increase varied among individuals. The most commonly reported symptoms after switching from smoking to vaping are constipation, fatigue, and visual changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Based on the small number of case reports, complete switching from tobacco smoking to e-cigarette vaping may have a similar effect on clozapine plasma concentrations and C\/D ratios as smoking cessation without vaping. The authors found no research on the impact of vaping on clozapine concentrations and C\/D ratios in people who had never smoked.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001476","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:00:40Z","timestamp":1779883240000},"page":"742-750","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Switching From Smoking to Vaping on Clozapine Concentration\u2013Dose Ratios and Plasma Clozapine Concentrations: A Systematic Review of Case Reports"],"prefix":"10.1097","volume":"48","author":[{"given":"Somtochukwu D.","family":"Uche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"McNeill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"R1-20261106","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Brauer","year":"2024","journal-title":"Lancet"},{"key":"R4-20261106","year":"2025","journal-title":"Public Health Profiles"},{"key":"R5-20261106","doi-asserted-by":"crossref","first-page":"18508","DOI":"10.1038\/s41598-025-93256-2","article-title":"Smoking prevalence and correlates among inpatients with schizophrenia or schizoaffective disorder","volume":"15","author":"Wu","year":"2025","journal-title":"Sci Rep"},{"key":"R6-20261106","first-page":"38","article-title":"Prevalence of cigarette smoking in schizophrenic patients compared to other hospital admitted psychiatric patients","volume":"1","author":"Ziaaddini","year":"2009","journal-title":"Addict Health"},{"key":"R8-20261106","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1007\/s11469-023-01058-2","article-title":"Differences in smoking cessation behaviors and vaping status among adult daily smokers with and without depression, anxiety, and alcohol use: findings from the 2018 and 2020 international tobacco control four country smoking and vaping (ITC 4CV) surveys","volume":"22","author":"Yimsaard","year":"2023","journal-title":"Int J Ment Health Addict"},{"key":"R9-20261106","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1186\/s12889-020-09308-x","article-title":"Mental health, smoking, harm reduction and quit attempts\u2014a population survey in England","volume":"20","author":"Brose","year":"2020","journal-title":"BMC Public Health"},{"key":"R10-20261106","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/08901171231224864","article-title":"Past-year mental illness diagnosis and E-cigarette use status among a college-aged sample: findings from the National college Health Assessment (2017-2019)","volume":"38","author":"Do","year":"2024","journal-title":"Am J Health Promot"},{"key":"R11-20261106","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12916-023-02890-y","article-title":"Associations between smoking and vaping prevalence, product use characteristics, and mental health diagnoses in Great Britain: a population survey","volume":"21","author":"Taylor","year":"2023","journal-title":"BMC Med"},{"issue":"1","key":"R12-20261106","article-title":"Electronic cigarettes for smoking cessation","volume":"1","author":"Lindson","year":"2025","journal-title":"Cochrane Libr"},{"key":"R13-20261106","doi-asserted-by":"crossref","first-page":"e2454962","DOI":"10.1001\/jamanetworkopen.2024.54962","article-title":"Prevalence of popular smoking cessation aids in England and associations with quit success","volume":"8","author":"Jackson","year":"2025","journal-title":"JAMA Netw Open"},{"key":"R14-20261106","doi-asserted-by":"crossref","first-page":"e0000007","DOI":"10.1371\/journal.pmen.0000007","article-title":"Moderation of the real-world effectiveness of smoking cessation aids by mental health conditions: a population study","volume":"1","author":"Jackson","year":"2024","journal-title":"PLOS Ment Health"},{"key":"R15-20261106","first-page":"e72039","article-title":"Breaking the myths around E-Cigarettes: a narrative review exploring the impact of e-Cigarette on human health","volume":"16","author":"Zohara","year":"2024","journal-title":"Cureus"},{"key":"R16-20261106","doi-asserted-by":"crossref","first-page":"113179","DOI":"10.1016\/j.fct.2022.113179","article-title":"Carcinogenic components of tobacco and tobacco smoke: a 2022 update","volume":"165","author":"Li","year":"2022","journal-title":"Food Chem Toxicol"},{"key":"R17-20261106","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa1916433","article-title":"Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI","volume":"382","author":"Blount","year":"2020","journal-title":"N Engl J Med"},{"key":"R18-20261106","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/add.70017","article-title":"The impacts of e-cigarette flavours: an overview of systematic reviews","volume":"120","author":"Livingstone-Banks","year":"2025","journal-title":"Addiction"},{"key":"R21-20261106","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41591-022-02201-7","article-title":"Nicotine e-cigarettes as a tool for smoking cessation","volume":"29","author":"Warner","year":"2023","journal-title":"Nat Med"},{"key":"R31-20261106","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/JCP.0000000000001954","article-title":"Expanding insights on clozapine dosing: the role of gender, smoking, and the clozapine\/norclozapine ratio","volume":"45","author":"Grover","year":"2025","journal-title":"J Clin Psychopharmacol"},{"key":"R32-20261106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.9734\/jammr\/2024\/v36i75484","article-title":"A review of the effect of vaping on the plasma levels of clozapine and its clinical implications","volume":"36","author":"Harry","year":"2024","journal-title":"J Adv Med Med Res"},{"key":"R33-20261106","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R35-20261106","first-page":"38","article-title":"The CARE guidelines: consensus-based clinical case reporting guideline development","volume":"2","author":"Gagnier","year":"2013","journal-title":"BMJ Case Rep"},{"key":"R36-20261106","first-page":"314","article-title":"Clozapine and the electronic cigarette; a case study","volume":"58","author":"Nonner","year":"2016","journal-title":"Tijdschr Psychiatr"},{"key":"R37-20261106","first-page":"A9090","article-title":"Switching to E-cigarettes affects drug concentration","volume":"159","author":"Berm","year":"2015","journal-title":"Ned Tijdschr Geneeskd"},{"key":"R38-20261106","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/JCP.0000000000000899","article-title":"Supatherapeutic plasma clozapine concentration after transition from traditional to electronic cigarettes","volume":"38","author":"Khorassani","year":"2018","journal-title":"J Clin Psychopharmacol"},{"key":"R39-20261106","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/JCP.0000000000000948","article-title":"Switching from tobacco smoking to electronic cigarettes and the impact on clozapine levels","volume":"38","author":"Kocar","year":"2018","journal-title":"J Clin Psychopharmacol"},{"key":"R40-20261106","doi-asserted-by":"crossref","first-page":"365","DOI":"10.9740\/mhc.2021.11.365","article-title":"Fluctuation between cigarette smoking and use of electronic nicotine delivery systems: impact on clozapine concentrations and clinical effect","volume":"11","author":"Montville","year":"2021","journal-title":"Ment Health Clin"},{"key":"R41-20261106","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/a-1221-5293","article-title":"Lack of smoking effects on pharmacokinetics of oral paliperidone-analysis of a naturalistic therapeutic drug monitoring sample","volume":"54","author":"Schoretsanitis","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"R42-20261106","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1176\/appi.focus.20190025","article-title":"Clinical issues to consider for clozapine patients who vape: a case illustration","volume":"18","author":"Blacker","year":"2020","journal-title":"Focus"},{"key":"R43-20261106","first-page":"2","article-title":"Altered clozapine concentrations associated with e-cigarettes","volume":"30","author":"Lam","year":"2018","journal-title":"Brown Univ Psychopharmacol"},{"key":"R44-20261106","first-page":"73","article-title":"An international guideline for making clozapine titration safer by using six ancestry based personalized dosing titrations, CRP, clozapine levels","volume":"55","author":"de Leon","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"R45-20261106","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/acps.13228","article-title":"Impact of smoking behavior on clozapine blood levels - a systematic review and meta-analysis","volume":"142","author":"Wagner","year":"2020","journal-title":"Acta Psychiatr Scand"},{"key":"R46-20261106","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00004714-200112000-00005","article-title":"Individual changes in clozapine levels after smoking cessation: results and a predictive model","volume":"21","author":"Meyer","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R47-20261106","first-page":"137","article-title":"Changes in plasma clozapine levels after smoking cessation in Japanese inpatients with schizophrenia: a retrospective cohort study","volume":"76","author":"Tsukahara","year":"2022","journal-title":"Acta Med Okayama"},{"key":"R48-20261106","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0447.2009.01482.x","article-title":"A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine","volume":"121","author":"Cormac","year":"2010","journal-title":"Acta Psychiatrica Scand"},{"key":"R49-20261106","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/JCP.0000000000001909","article-title":"Plasma clozapine and N- desmethylclozapine (norclozapine) concentrations and the clozapine\/norclozapine ratio","volume":"44","author":"Flanagan","year":"2024","journal-title":"J Clin Psychopharmacol"},{"key":"R50-20261106","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/hup.1191","article-title":"Factors affecting interindividual differences in clozapine response: a review and case report","volume":"26","author":"Bersani","year":"2011","journal-title":"Hum Psychopharmacol"},{"key":"R51-20261106","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-2125.2011.04023.x","article-title":"Effect of nicotine on cytochrome P450 1A2 activity","volume":"72","author":"Hukkanen","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"R52-20261106","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-2007-1014307","article-title":"Seizures following smoking cessation in a clozapine responder","volume":"27","author":"McCarthy","year":"1994","journal-title":"Pharmacopsychiatry"},{"key":"R53-20261106","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.jcp.0000106221.36344.4d","article-title":"Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients","volume":"24","author":"Rostami-Hodjegan","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R54-20261106","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/jrpp.jrpp_37_23","article-title":"Influence of cigarette smoking habit on clozapine-to- norclozapine ratio in male patients","volume":"12","author":"Lozano","year":"2023","journal-title":"J Res Pharm Pract"},{"key":"R55-20261106","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1021\/acs.chemrestox.8b00063","article-title":"Evaluation of E-Vapor nicotine and nicotyrine concentrations under various E-Liquid compositions, device settings, and vaping topographies","volume":"31","author":"Son","year":"2018","journal-title":"Chem Res Toxicol"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:00:37Z","timestamp":1793977237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001476","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"2025-12-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}